Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05814575 · ClinicalTrials.gov registry record · NA

NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
103
Enrollment target

NCT05814575: Completed NA study, sponsored by Virginia Commonwealth University.

NCT05814575 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 103 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05814575, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
103 participants
Enrollment target

Study Summary

This exploratory study brings together an interprofessional team, novel tools, and innovative, community-driven care delivery approaches to improve health equity among mother-infant dyads impacted by substance use disorder and high risk for poor health outcomes. This study will test a community-informed and community-based intervention using a fetal ultrasound protocol, motivational interviewing techniques, strength-based education, and healthcare coordination strategies to reduce health disparities faced by women and their children.

Primary Outcome

Percentage of each group returning for a second study visit

Interventions

  • BEHAVIORAL NEXUS intervention
  • BEHAVIORAL Standardized Non-Medical fetal ultrasound

Trial Details

FieldValue
Enrollment Target 103 participants
Start Date 2023-06-08
Est. Completion 2025-11-30
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT05814575 record still lists

NCT05814575 is an interventional study that assigns participants to a tested intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which NEXUS intervention is the first listed.

NCT05814575 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05814575 about?

NCT05814575 is a clinical study titled "NEXUS - Next Generation Health Through 2D & 3D Fetal UltraSound; Building Connections to Support Maternal-fetal Health". This exploratory study brings together an interprofessional team, novel tools, and innovative, community-driven care delivery approaches to improve health equity among mother-infant dyads impacted by substance use disorder and high risk for poor health outcomes. This study will test a community-info...

What is the current status of trial NCT05814575?

This trial is currently completed. It is a NA study. The enrollment target is 103 participants. The study started on 2023-06-08. Estimated completion is 2025-11-30.

What interventions are being tested in trial NCT05814575?

The interventions under investigation include: NEXUS intervention (BEHAVIORAL), Standardized Non-Medical fetal ultrasound (BEHAVIORAL).

Who is sponsoring clinical trial NCT05814575?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05814575's enrollment target sits among peer trials

103 837th of 2000 higher than 1,164 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04690348 · 103 participants · Phase 2

    Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study

  • NCT05282277 · 103 participants · Phase 4

    Examining the Effects of Estradiol on Neural and Molecular Response to Reward

  • NCT05566769 · 103 participants · NA

    Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  • NCT05834478 · 103 participants · Phase 3

    Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05814575, the US trial registry maintained by the National Library of Medicine. NCT05814575 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.